the incidence of proximal deep vein thrombosis was reduced from 18.5 % in the unfractionated heparin group to 7.5 % in the enoxaparin group ( p = 0.014 ) , and the incidence of total deep vein thrombosis was similarly reduced from 25 % to 12.5 % ( p = 0.03 ) .
C0206460
enoxaparin
C0042487
of